A case with massive hemobilia long-term after internal drainage surgery for congenital biliary dilation

Shunryo Minezaki1, Takeyuki Misawa2, Makoto Watanabe1

  • 1Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-Ku, Tokyo, 173-8606, Japan.

Insights

Internal drainage surgery for congenital biliary dilation (CBD) can lead to delayed complications, including bile duct bleeding and cancer. This case highlights the long-term risks associated with this obsolete procedure.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Hepatobiliary Surgery

Background:

  • Congenital biliary dilation (CBD) surgery has evolved, with extrahepatic bile duct resection and choledochojejunostomy now standard.
  • Internal drainage surgery (IDS), an older CBD treatment, is obsolete due to cancer risks but its long-term pathology remains unclear.

Purpose of the Study:

  • To report a rare case of severe bile duct bleeding and incidental cholangiocarcinoma 62 years after IDS for CBD.
  • To emphasize the potential long-term risks of remnant bile ducts after obsolete IDS procedures.

Main Methods:

  • A case report of an 82-year-old woman presenting with hemorrhagic shock due to gastrointestinal bleeding.
  • Diagnosis of pseudoaneurysm rupture in the remnant bile duct after prior IDS for CBD.
  • Management involved emergency transcatheter arterial embolization (TAE) followed by elective bile duct resection and choledochojejunostomy.

Main Results:

  • Successful hemostasis achieved via TAE for life-threatening bile duct bleeding.
  • Pathological examination revealed chronic inflammation and incidentally detected early-stage cholangiocarcinoma (Tis, N0, M0, pStage 0).

Conclusions:

  • Long-standing chronic inflammation in remnant bile ducts after IDS poses risks of life-threatening bleeding and carcinogenesis.
  • Accurate patient history regarding prior CBD surgical procedures is crucial for diagnosing hemobilia.
Abstract